TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2022 ,inter alia, to consider and approve 1. A meeting of the Board of Directors will be held on Wednesday, 25-May-22, inter alia, to consider and approve the Audited Financial Results of the Company for the year ended on 31-Mar-22. 2. In the above meeting, the Board would also consider the following: i. Recommendation of final dividend, if any, on the equity shares of the Company, for the year 2021-22. ii. Taking enabling resolutions for raising of funds by issue of Equity Shares including Convertible Bonds / Debentures through Qualified Institutional Placement (QIP) and / or Depository Receipts or any other modes. If approved by the Board of Directors, the said item will be placed for Shareholders'' approval in the ensuing Annual General Meeting.